archive-fr.com » FR » I » IT-INITIATIVE.FR

Total: 133

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Recent Investments
    Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development Michel Berg CEO Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development This is a vote of confidence in the Bioaxial team and its technology Philippe BRAITBART CEO Novel solutions for sustainable intraocular production of therapeutic proteins We are truly grateful for ITI s triggering our partnership with Boehringer Ingelheim Venture Fund as a new shareholder of Eyevensys Ivan Cohen Tanugi CEO Novel compounds for the treatment of inner ear

    Original URL path: http://www.it-initiative.fr/portfolio/recent-investments?style=red (2015-10-11)
    Open archived version from archive


  • Recent Investments
    Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development Michel Berg CEO Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development This is a vote of confidence in the Bioaxial team and its technology Philippe BRAITBART CEO Novel solutions for sustainable intraocular production of therapeutic proteins We are truly grateful for ITI s triggering our partnership with Boehringer Ingelheim Venture Fund as a new shareholder of Eyevensys Ivan Cohen Tanugi CEO Novel compounds for the treatment of inner ear

    Original URL path: http://www.it-initiative.fr/portfolio/recent-investments?style=orange (2015-10-11)
    Open archived version from archive

  • Recent Investments
    Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation TMS Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development Michel Berg CEO Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Beyond its participation in our capital ITI s expertise is a key asset for the success of our company and in particular our international development This is a vote of confidence in the Bioaxial team and its technology Philippe BRAITBART CEO Novel solutions for sustainable intraocular production of therapeutic proteins We are truly grateful for ITI s triggering our partnership with Boehringer Ingelheim Venture Fund as a new shareholder of Eyevensys Ivan Cohen Tanugi CEO Novel compounds for the treatment of inner ear

    Original URL path: http://www.it-initiative.fr/portfolio/recent-investments?style=blue (2015-10-11)
    Open archived version from archive

  • Exits Portfolio
    to raise 1 3 million to finance the development of a treatment of cannabis addiction Cécile Tharaud appointed as President and Managing Partner of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation

    Original URL path: http://www.it-initiative.fr/portfolio/exits-portfolio?style=green (2015-10-11)
    Open archived version from archive

  • Exits Portfolio
    to raise 1 3 million to finance the development of a treatment of cannabis addiction Cécile Tharaud appointed as President and Managing Partner of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation

    Original URL path: http://www.it-initiative.fr/portfolio/exits-portfolio?style=red (2015-10-11)
    Open archived version from archive

  • Exits Portfolio
    to raise 1 3 million to finance the development of a treatment of cannabis addiction Cécile Tharaud appointed as President and Managing Partner of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation

    Original URL path: http://www.it-initiative.fr/portfolio/exits-portfolio?style=orange (2015-10-11)
    Open archived version from archive

  • Exits Portfolio
    to raise 1 3 million to finance the development of a treatment of cannabis addiction Cécile Tharaud appointed as President and Managing Partner of Inserm Transfert Initiative InotremRaises 18 million to Develop Innovative Sepsis Treatmentsin a Series A Financing Co led by Edmon de Rothschild Investment Partners and Sofinnova Partners Axilum Robotics announces Health Canada licence for TMS Robot the world s first robot developed specifically for Transcranial Magnetic Stimulation

    Original URL path: http://www.it-initiative.fr/portfolio/exits-portfolio?style=blue (2015-10-11)
    Open archived version from archive

  • People
    CEO Inserm Transfert Initiative Dr François Thomas is President of Inserm Transfert Initiative ITI He is a medical oncologist and a former assistant professor at the Gustave Roussy Institute He also holds an MBA from MIT Boston François Thomas was successively vice president VP for clinical development of Ipsen managing partner of Bioserve Ltd VP in charge of pharmacogenomic programs and licensing at Genset partner in the venture capital firm Atlas Venture in charge of healthcare banking activities at Bryan Garnier and president of Cytheris His professional activity over the last 15 years has been dedicated to the creation and development of biotech companies in Europe Office Manager Before joining Inserm Transfert Initiative Nelly Picardat worked since 2007 within the presidency and the head office of different start ups in biotechnology and trade medicine Nelly Picardat worked as executive assistant in the department on Prevention Screening and Information at INCa Institut National du Cancer and LNCC Ligue Nationale contre le Cancer She graduated from ISEFAC ISEG Group BTS Management Assistant and has a diploma of the economic and social baccalaureat Advisor D r Jean Jacques Garaud is a senior executive with a broad experience in Research and Development in the

    Original URL path: http://www.it-initiative.fr/people?style=green (2015-10-11)
    Open archived version from archive